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OBJECTIVES The study was done to determine the interaction of coronary artery calcium and diabetes
mellitus for prediction of all-cause death.
BACKGROUND Diabetes is a strong risk factor for coronary artery disease (CAD) and is associated with an
elevated overall mortality. Electron beam tomography (EBT) provides information on the
presence of subclinical atherosclerosis and may be useful for risk stratification.
METHODS We followed 10,377 asymptomatic individuals (903 diabetic patients) referred for EBT
imaging. Primary end point was all-cause mortality, and the average follow-up was 5.0  3.5
years. Cox proportional hazard models, with and without adjustment for other risk factors,
were developed to predict all-cause mortality.
RESULTS Patients with diabetes had a higher prevalence of hypertension and smoking (p  0.001) and
were older. The average coronary calcium score (CCS) for subjects with and for those without
diabetes was 281 567 and 119 341, respectively (p 0.0001). Overall, the death rate was
3.5% and 2.0% for subjects with and without diabetes (p  0.0001). In a risk-factor–adjusted
model, there was a significant interaction of CCS with diabetes (p  0.00001), indicating
that, for every increase in CCS, there was a greater increase in mortality for diabetic than for
nondiabetic subjects. However, patients suffering from diabetes with no coronary artery
calcium demonstrated a survival similar to that of individuals without diabetes and no
detectable calcium (98.8% and 99.4%, respectively, p  0.5).
CONCLUSIONS Mortality from all causes is increased in asymptomatic patients with diabetes in proportion to
the screening CCS. Nonetheless, subjects without coronary artery calcium have a low
short-term risk of death even in the presence of diabetes mellitus. (J Am Coll Cardiol 2004;
43:1663–9) © 2004 by the American College of Cardiology Foundationd
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ss a marker of atherosclerotic burden, coronary artery
alcium has been found to be more prevalent and more
xtensive in diabetic patients (1–3). The most recent guide-
ines of the National Cholesterol Education Program rec-
mmend that diabetes mellitus be considered a coronary
rtery disease (CAD) equivalent, owing to the high inci-
ence of atherosclerosis-related events in patients suffering
rom this ailment (4–8). Despite the high prevalence of
oronary artery calcium, it remains to be determined
hether screening diabetic patients with electron beam
omography (EBT) to detect subclinical disease improves a
hysician’s ability to predict events. Furthermore, it is
nclear whether a patient with diabetes but without detect-
ble coronary artery calcium carries a risk of cardiovascular
vents similar to that of a subject with no diabetes and no
vidence of coronary atherosclerosis. For the purpose of this
nalysis we utilized the U.S. National Death Registry to
erify all-cause mortality in a cohort of 10,377 asymptom-
tic individuals submitted to EBT screening for coronary
alcification between 1996 and 2000 at one clinical center.
urvival data were analyzed in subjects with and without
From the *Tulane University School of Medicine, New Orleans, Louisiana;
Atlanta Cardiovascular Research Institute, Atlanta, Georgia; ‡Cedars Sinai Medical
enter, Los Angeles, California; and §EBT Research Foundation, Nashville, Ten-
essee. Dr. Roger Blumenthal acted as Guest Editor for this report.
Manuscript received August 14, 2003; revised manuscript received September 24,t003, accepted September 29, 2003.iabetes, and survival curves were compared in the two
roups according to their baseline coronary calcium score
CCS).
ATERIALS AND METHODS
atient selection. We followed 10,377 asymptomatic in-
ividuals referred by their primary care physician between
996 and 2000 for coronary calcium screening with EBT.
ndividuals were referred for screening based upon the
resence of established risk factors for atherosclerosis, and as
uch were not an unselected cohort representative of the
eneral population. All subjects were initially screened by an
nternist and had at least one of the following CAD risk
actors: diabetes mellitus, systemic hypertension, hypercho-
esterolemia, current smoking, and a family history of
remature CAD. Patients with a prior history of CAD
including hospital admission for chest pain, acute coronary
yndromes, or prior coronary revascularization) were
xcluded.
ata collection. Information regarding the presence of
ategorical cardiac risk factors was collected in every patient
y written questionnaires. Systemic arterial hypertension
as defined as a documented history of high blood pressure
r treatment with antihypertensive medications. Current
moking or cessation of smoking within three months of
esting was defined as positive smoking status. Hypercho-
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Value of Coronary Calcium Screening May 5, 2004:1663–9esterolemia was defined as known but untreated hypercho-
esterolemia or current treatment with lipid-lowering med-
cations. Individuals were classified as affected by diabetes if
hey carried an established diagnosis of diabetes mellitus
ade by a physician and/or were receiving treatment with
nsulin or oral hypoglycemic agents. An estimated Framing-
am risk score was calculated on each patient, and the
ethodology has been previously reported from this data set
9).
lectron beam tomography. Patients signed an informed
onsent to undergo screening by EBT and to release their
edical records for the purpose of conducting clinical
esearch. The EBT imaging was performed on either an
matron C-100 or a C-150 scanner (GE-Imatron, South
an Francisco, California). Thirty-six to 40 contiguous
-mm-thick tomographic sections were obtained starting at
he level of the carina and extending to the diaphragm with
00-ms scan time per section. Tomographic imaging was
lectrocardiographically triggered at 60% to 80% of the RR
nterval. Coronary calcification was defined as a plaque of at
east three contiguous pixels (voxel size  1.03 mm3) with
n attenuation 130 HU. Quantitative CCSs were calcu-
ated according to the method described by Agatston et al.
10). All EBT scans were reviewed by either one of two
xperienced investigators (P.R. and T.Q.C.) in random
rder on a NetraMD workstation (ScImage, Los Altos,
alifornia). Because calcium scoring was performed for
linical purposes and not for research purposes it was
alculated only once for each patient. Although both intra-
nd interobserver score variabilities are not available for this
tudy, prior local verification and published evidence re-
ealed a median interscan and interreader variability of 8%
o 10% (11,12).
ollow-up procedures. The occurrence of all-cause death
as verified by the National Death Index. All screened
ndividuals provided informed consent for follow-up, and
ur human investigations committee approved procedures
or follow-up, including review of medical records. The
verage follow-up interval between the time of EBT screen-
ng and the verification of death via the National Death
ndex was 5  3.5 years (range 2 to 5 years).
tatistical analysis and estimation of risk. The primary
nd point for this analysis was time to all-cause mortality.
reliminary comparative analyses included statistical com-
arison of traditional cardiac risk factors and CCS in both
iabetic and nondiabetic individuals. For comparisons of
ategorical variables, a chi-square statistic was employed.
Abbreviations and Acronyms
CAD  coronary artery disease
CCS  coronary calcium score
CI  confidence interval
EBT  electron beam tomography
ROC  receiver operating characteristicor comparisons of statistical differences in the average age df diabetic and nondiabetic subjects, a univariable analysis of
ariance test was applied. Both univariable and multivariable
ox proportional hazards survival models were employed to
ssess time to demise. Initially, cumulative differences in
urvival between subjects with and without diabetes were
ompared using an unadjusted (i.e., univariable) Cox pro-
ortional hazards model for time to five-year survival. A
tratified (by diabetic status) Cox proportional hazards
odel was employed to compare all-cause survival by CCS
or subjects with and without diabetes. In subset analyses of
iabetic individuals, stratified Cox models were also em-
loyed to calculate all-cause survival by CCS for female,
ypercholesterolemic, elderly (i.e., age 70 years), and
ypertensive diabetic patients. A first-order test for inter-
ction was employed to evaluate survival differences in
atients with and without diabetes with a CCS of 0 versus
0.
A multivariable (or risk factor-adjusted) Cox proportional
azards survival model was calculated to evaluate the statis-
ical significance of traditional risk factors (i.e., age, gender,
ypertension, hyperlipidemia, smoking, and family history
f premature coronary disease) and of CCS in diabetes and
o-diabetes subsets. Candidate variables included those
ith an initial p  0.10 based upon the univariable analysis.
he final model included all variables with a p  0.20.
Finally, a receiver operating characteristic (ROC) curve
as utilized to evaluate the event classification ability for
stimated Framingham risk score and CCS in the predic-
ion of all-cause mortality (9).
ESULTS
omparison of traditional risk factors. The clinical char-
cteristics of the 10,377 subjects are shown in Table 1
bout 10% of the subjects were affected by diabetes melli-
us, and men and women were equally represented in either
atient cohort. Hypertension and smoking were more prev-
lent in subjects with diabetes, whereas family history of
AD was less prevalent in this group (Table 1).
ll-cause mortality rates in patients with and without
iabetes. The Cox survival curves showed that overall
ortality was significantly greater (chi-square  43, p 
.0001) in patients with diabetes than in those without
able 1. Clinical Characteristics of the 10,377 Asymptomatic
ubjects Undergoing Coronary Calcium Screening With
lectron Beam Tomography
Diabetes
(n  903)
No Diabetes
(n  9,474) p Value
ge 57  10 53  10  0.0001
omen 43.0% 40.1% 0.10
ypertension 63.2% 41.7%  0.0001
amily history of premature
coronary disease
64.5% 69.1% 0.005
yperlipidemia 64.0% 60.1% 0.112
urrent smoker 44.1% 39.2% 0.005
ean  SD or percent.iabetes (Fig. 1). Furthermore, when comparing risk-factor
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May 5, 2004:1663–9 Value of Coronary Calcium Screeningubsets, all-cause mortality was greater in patients with
iabetes (Table 2). Statistically significant differences in
ll-cause mortality were noted for several patient subsets,
ncluding the elderly (i.e., age 70 years), hypertensive
ubjects, and current smokers. As an example, five-year
ortality was 15.8% and 7.8% for individuals with diabetes
nd without diabetes, respectively, 70 years of age and older
p  0.05 for all comparisons of diabetic vs. nondiabetic
ndividuals).
ll-cause survival by CCS. Figure 2 shows the survival
urves for subjects with and without diabetes mellitus
ccording to the amount of coronary calcium found at the
ime of EBT screening. As shown, mortality increased with
ncreasing baseline CCS levels for both diabetic and non-
iabetic individuals and was highest in subjects with a CCS
400. In a risk-adjusted model, there was a significant
nteraction of CCS with diabetes (p  0.00001), indicating
able 2. All-Cause Mortality Rates by Clinical Characteristics
n the Study Population
Diabetes
(n  903)
No Diabetes
(n  9,474)
Survivors Deceased Survivors Deceased
ge 70 yrs 84.2% 15.8% 92.2% 7.8%
omen 94.8% 5.2% 97.8% 2.2%
ypertension 92.3% 7.7% 97.2% 2.8%
amily history of premature
coronary disease
95.0% 5.0% 98.1% 1.9%
yperlipidemia 95.3% 4.7% 98.2% 1.8%
urrent smoker 93.0% 7.0% 96.8% 3.2%
Figure 1. Cox proportional hazards survival modem 0.05 for all comparisons of diabetic vs. nondiabetic individuals.hat for every increase in CCS there was a greater increase
n mortality for diabetic compared to nondiabetic subjects.
Five-year all-cause survival was similar for diabetic and
ondiabetic individuals with no coronary calcium at the time of
BT screening (Fig. 3) (survival, 98.8% vs. 99.4%, respectively,
 0.49). These similarities were noted despite the greater
revalence of hypertension (59% vs. 35% in nondiabetic sub-
ects, p  0.0001), women (57% vs. 49% in nondiabetic
ubjects, p  0.0001), and older age (mean, 52  9 vs. 49 
years in nondiabetic subjects, p  0.0001) in the diabetic
atient cohort with a calcium score of 0. Using a first-order test
or interaction, no significant differences existed in survival
etween diabetic subjects and nondiabetic individuals with a
alcium score of 0 (p 0.19). The statistical power of this test
as: beta  0.47 for alpha  0.05.
ortality with diabetes and other co-morbidities. Table
shows a pattern of increasing mortality with higher
aseline calcium scores in diabetic subjects affected by other
o-morbidities. The trend was evident in diabetic women,
ypercholesterolemic subjects, hypertensive subjects, and
he elderly (70 years of age).
ultivariable models estimating mortality. In a multiva-
iable model, predictors of all-cause mortality in subjects
ffected by diabetes mellitus were age, systemic hyperten-
ion, smoking, and CCS (Table 4). There was a 44% (95%
onfidence interval [CI] 20% to 80%) increased risk of death
or every increase in CCS grouping from 11 to 100 to 101
o 400, 401 to 1,000, and 1,000 (p  0.0001). Individuals
ithout diabetes mellitus demonstrated similar predictors of
ulative risk-adjusted mortality by diabetes status.ortality as did the diabetic subjects. Although hypercho-
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Value of Coronary Calcium Screening May 5, 2004:1663–9esterolemia was not an independent predictor of all-cause
eath in diabetic patients (Table 4), it was associated with
ecreased all-cause mortality in nondiabetic subjects (Table 5).
Based upon the Framingham risk equation, all of the 903
iabetic subjects were considered high risk, whereas 62%
nd 24% of the nondiabetic subjects were intermediate and
igh risk, respectively (p  0.0001). We then compared the
dded value of the CCS in estimating all-cause mortality
ver and above an estimated Framingham risk score by
eans of an ROC curve. For nondiabetic patients, the
-index for the Framingham risk score was 0.61 (95% CI
.57 to 0.65, p  0.0001) but increased to 0.70 when CCS
as used (95% CI 0.66 to 0.74, p  0.0001). For diabetic
atients, the C-index was substantially higher for the CCS
igure 2. Cox proportional hazards survival (n  10,377) by electron be
iabetes mellitus (chi-square  204, p  0.0001). The number of subject
igure 3. Cox proportional hazards cumulative survival for subjects with a
n each calcium score category is in parentheses.C-index, 0.72, 95% CI 0.64 to 0.79, p  0.0001) when
ompared with the estimation of mortality based upon the
ramingham risk score alone (C-index, 0.50, 95% CI 0.42
o 0.58, p  1.0).
ISCUSSION
atients affected by diabetes mellitus have been shown to
ave extensive coronary artery calcium deposits on EBT
maging (1–3). In this large observational study, we showed
hat the presence of any degree of coronary artery calcium in
atients with diabetes mellitus portends a higher risk for
ll-cause mortality than in nondiabetic patients. Addition-
lly, the absence of coronary artery calcium indicated a low
mography coronary calcium measurements in subjects with and without
ach calcium score category is in parentheses.
thout diabetes mellitus with a calcium score of 0. The number of subjectsam tond wi
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May 5, 2004:1663–9 Value of Coronary Calcium Screeninghort-term risk of death for diabetic patients as well as
ubjects without diabetes. Hence, the absence of measurable
therosclerosis appears to be an important modifier of
utcome even in the presence of established severe risk
actors for atherosclerosis such as diabetes mellitus.
Our clinical experience closely resembles the observations
ecently made by Kang et al. (13) and Giri et al. (14). In
hose studies, patients affected by diabetes mellitus who
nderwent a stress myocardial perfusion single-photon
mission computed tomography had a much greater risk of
cute coronary events and death than did nondiabetic
ndividuals for any degree of demonstrable perfusion abnor-
ality. Similar data were published by Marwick and col-
eagues (15) using stress echocardiographic techniques.
aken together, these findings suggest that any extent of
isease burden is more dangerous in diabetic patients than
n nondiabetic individuals.
Because the risk of CAD-related events in patients with
iabetes mellitus is as high as that of individuals with known
AD, diabetes is currently considered a CAD equivalent.
n general, the findings on EBT imaging studies corrobo-
ate this clinical observation. In fact, the amount of coronary
rtery calcium detected by EBT in diabetic patients without
stablished CAD is similar to that of nondiabetic subjects
ith known CAD (16,17). Furthermore, diabetes mellitus
bolishes the well-known advantage of women over men in
revalence and extent of coronary artery calcium and ath-
rosclerosis burden (18,19). However, the notion of diabetes
s a CAD equivalent may not apply to diabetic subjects
ithout evidence of coronary atherosclerosis by EBT. In
his subset, which represented 30% of the diabetic patients
n our cohort, the short-term mortality risk was equivalent
o that of nondiabetic subjects. These findings imply that
Table 3. Cox Proportional Hazards 5-Year Su
Electron Beam Tomography Coronary Calcium
Hyperlipidemic, Hypertensive, and Elderly (
Coronary Calcium Score 0–10
Female diabetic patients 97.8%
2  55, p 
Hyperlipidemic diabetic patients 98.2%
2  54, p 
Hypertensive diabetic patients 97.3%
2  47, p 
Elderly (70 yrs) diabetic patients 94.6%
2  34, p 
Table 4. Multivariable Model Predicting All-C
Patients Undergoing Coronary Calcium Screen
Relative Risk
Ratio
9
Age 1.06
Hypertension 3.76
Hyperlipidemia 0.72
Current smoker 1.76
Coronary calcium 1.44Model chi-square  67, p  0.0001. Calcium categories  0–10,oronary calcium screening may identify a subgroup of
iabetic patients who are at low risk of death, although
onfatal CAD events are of additional concern and could
till occur.
The mechanisms causing the extensive accumulation of
alcium in the arterial system of patients affected by diabetes
ellitus are largely unknown but are likely multifactorial.
lthough pathological studies have demonstrated that the
mount of calcium per plaque area is similar among diabetic
nd nondiabetic patients (20), diabetics tend to have a larger
therosclerotic plaque burden (18), likely explaining the
bserved larger amount of coronary calcium. Recent evi-
ence indicates that advanced glycation end-products in-
uce the expression of genes and enzymes involved in the
ctive calcification processes taking place in the atheroscle-
otic plaque (21,22). In fact, hyperglycemia induces the
xpression of the bone morphogenic enzyme osteopontin in
ascular smooth muscle cells (22). Osteopontin is in turn
apable of inducing the expression of platelet-derived
rowth factor (22). Hence, hyperglycemia may initiate a
ro-atherogenic and pro-thrombotic effect that ultimately
esults in calcification of the plaque. Vascular calcification in
iabetic subjects is not limited to calcification in the
ubintimal space, but extends to the medial layer of the
essel wall (23,24). Though not associated with typical
therosclerotic processes, this form of calcification also
oses a very substantial risk of cardiovascular events in
iabetic patients (24) and can contribute to the larger degree
f calcification seen in diabetes mellitus.
Diabetes mellitus carries a very high risk for cardiovas-
ular complications; unfortunately, the incidence rates of
his ailment and that of obesity and the metabolic syn-
rome—a precursor of diabetes—are rapidly increasing in
in Key Diabetic Patient Subsets Undergoing
asurements Including Female,
ears of Age) Diabetic Patients
11–100 101–400 401–1,000 >1,000
95.6% 93.8% 88.2% 71.4%
001
96.4% 95.3% 90.7% 79.8%
001
94.4% 92.0% 86.2% 70.0%
001
91.2% 86.1% 79.6% 59.8%
001
Mortality in Asymptomatic Diabetic
onfidence
tervals Chi-Square p Value
3–1.09 15  0.0001
9–8.77 9 0.003
1–1.26 1 0.24
9–3.11 4 0.05
6–1.80 10 0.001rvival
Me
70 Y
0.0
0.0
0.0
0.0ause
ing
5% C
In
1.0
1.5
0.4
0.9
1.111–100, 101–400, 401–1000, 1000.
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Value of Coronary Calcium Screening May 5, 2004:1663–9oth developed and developing countries (25–27). Several
acts render an early and accurate diagnosis of coronary
rtery atherosclerosis desirable in diabetes mellitus: the
ecrease in cardiovascular mortality in diabetic patients has
ot matched the decrease seen in the general population
28); diabetic patients are often asymptomatic even with
dvanced stages of CAD (6,7); and both the complication
nd mortality rates of diabetic patients with acute coronary
vents far outweigh that of nondiabetic subjects (29–31). At
he same time, recent evidence shows that aggressive med-
cal management of lipids and systemic hypertension in
iabetic patients led to a significant reduction in micro- as
ell as macrovascular disease along with a remarkable
eduction in risk of cardiovascular events (32–36). Thus,
creening for coronary artery calcium could prove to be a
seful tool to risk-stratify asymptomatic diabetic subjects
ith the ultimate goal to conduct a more or less aggressive
herapy tailored to the individual rather than the disease
tate.
Our findings differ in part from those of Qu et al. (37).
imilar to our report, the investigators noted an increased
isk of events in diabetic patients compared to nondiabetic
ubjects in the presence of coronary calcification (37).
owever, the investigators were unable to prove an inter-
ction between diabetic status and coronary calcium score as
e did in our study. Several important differences between
ur analyses should be noted. Qu et al. (37) studied a
maller cohort (1,312 individuals, 19% diabetic subjects) of
igh-risk subjects, mostly males and on average 10 years
lder than our patients. Furthermore, they used an EBT
maging protocol with reduced sensitivity for detection of
oronary calcium (38) and chose a combination of cardio-
ascular outcomes as their end point rather than all-cause
ortality. All of the above reasons may have contributed to
he substantial differences noted between our studies.
There were a few limitations to our report. First, we
tilized self-reported risk-factor categories without contin-
ous variables. We did not collect information that would
llow the clear distinction of insulin-dependent and insulin-
ndependent individuals. Nonetheless, coronary calcification
s equally increased in the two types of diabetes mellitus
Table 5. Multivariable Model Predicting All-C
Subjects Undergoing Coronary Calcium Screen
Relative R
Ratio
Age 1.06
Gender 1.25
Hypertension 1.41
Hyperlipidemia 0.64
Current smoker 2.37
Family history of premature coronary
disease
0.83
Coronary calcium 1.36
Model chi-square  252, p  0.0001. Calcium categories ompared to the general population (1–3,16,17,19) andisk-factor categories appear to be as robust as continuous
ariables for appraisal of risk (39). Our patients were
eferred by primary care physicians and may not have been
epresentative of the general population. We used all-cause
ortality as an end point for our study rather than a
ardiovascular end point. The use of all-cause mortality may
ctually reduce the amount of bias in classification of events
oted in previous reports (40); it is receiving ever-growing
pproval as an end point for cardiovascular outcome re-
earch (41). Furthermore, the majority of fatal events are
ardiovascular in nature in most developed and several
eveloping countries. Of note, studies from three different
ontinents showed that the risk of cardiovascular mortality
nd all-cause mortality associated with diabetes mellitus is
ery similar (42–44).
In summary, coronary artery calcification by EBT appears
o be a useful tool for risk stratification of subjects suffering
rom diabetes mellitus. Aggressive medical therapy should
e provided in the presence of calcification and potentially
ntensified according to the degree of coronary calcification.
atients suffering from diabetes mellitus and free of coro-
ary artery calcification are at low risk of death in the short
o intermediate time period.
eprint requests and correspondence: Dr. Paolo Raggi, Section
f Cardiology, Tulane University School of Medicine, 1430
ulane Ave., SL-48, New Orleans, Louisiana 70112. E-mail:
raggi@tulane.edu.
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